These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11961541)

  • 1. Microbiology: a resistance switch.
    O'Toole GA
    Nature; 2002 Apr; 416(6882):695-6. PubMed ID: 11961541
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
    Drenkard E; Ausubel FM
    Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilms, antimicrobial resistance, and airway infection.
    Prince AS
    N Engl J Med; 2002 Oct; 347(14):1110-1. PubMed ID: 12362015
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.
    Evans TJ
    Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and resistance to imipenem of Pseudomonas aeruginosa on latex gloves.
    Ballesta S; Conejo MC; García I; Rodríguez-Martínez JM; Velasco C; Pascual A
    J Antimicrob Chemother; 2006 May; 57(5):1010-2. PubMed ID: 16531426
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection.
    Lopes SP; Ceri H; Azevedo NF; Pereira MO
    Int J Antimicrob Agents; 2012 Sep; 40(3):260-3. PubMed ID: 22770521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the complexity of the pulmonary microbiology in cystic fibrosis: thoughts of a clinician.
    Katznelson D
    Isr Med Assoc J; 2006 Jan; 8(1):49-52. PubMed ID: 16450753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Foreign body infections--biofilms and quorum sensing].
    Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
    Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA; Soothill JS; Schiller NL
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
    Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa biofilms in hospital water systems and the effect of sub-inhibitory concentration of chlorine.
    Suman E; Singh S; Kotian S
    J Hosp Infect; 2008 Oct; 70(2):199-201. PubMed ID: 18723254
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell surface properties determine persistence of Pseudomonas aeruginosa.
    Liebens VR; De Groote VN; Fauvart M; Kint CI; Jans A; Vercruysse M; Verstraeten N; Michiels J
    Commun Agric Appl Biol Sci; 2011; 76(1):193-6. PubMed ID: 21539229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.